Orozco H, Mercado MA, Chan C, Ramos-Gallard G, Gálvez-Treviño R, Salgado-Nesme N, Cisneros De-ajuria R, Anthón FJ

Language: English
References: 21
Page: 175-178
PDF size: 41.53 Kb.

Text Extraction

Portal hypertension surgery has evolved widely in the last decades. Since the first surgical shunt was done in 1945 for the treatment of recurrent hemorrhage, many surgical options have been developed including selective shunts, low diameter shunts and extensive devascularization procedures. Many of them have been studied and compared showing their advantages and disadvantages, evolving also their role in the therapeutic armamentarium.
Surgery is nowadays a second line treatment option (after β blockers and endoscopic therapy), and it’s main indication is for patients whose main and only problem is history of bleeding, with good liver function (Child-Pugh A). For emergency situations it has a very limited role and for primary prophylaxis virtually has also no role. Patients with good liver function, electively operated with portal blood flow preserving procedures are the patients that benefit from surgical treatment. Patients with a bad liver function are better candidates for a liver transplant.

REFERENCES

1. Reichen J. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 1990;11:1066-78.

2. Bernard B, Lebrec D, Mathurin P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointstinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997;25:63-70.

3. Villanueva C, Balanzo J, Novella MT. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal bleeding. N Engl J Med 1996;334:1624-9.

4. Sauerbruch T, Wotzka R, Kopeke W et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med 1988;319:8-14.

5. Laine K, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal hemorrhage. Ann Intern Med 1995;123:280-7.

6. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.

7. Lo G, Lal K, Chang C, Jeng J, Chen S, Lin C, Chiang H. A prospective, randomized trial of injection sclerotherapy vs. Banding ligation in the management of bleeding esophageal varices. Gastroenterology 1994;106:A933.

8. Rossle M, Ilaag K, Ochs A, Scllinger M, Noldge G, Perarnau JM, Berger E et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;300:165-71.

9. Sanyal AJ, Freeman A, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20:46-55.

10. LaBerge JM, Somberg KA, Lake JR et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108;1143-51.

11. Fillmore DJ, Miller FJ, Fox LF, Disario JA, Tietze CC. Transjugular intrahepatic portosystemic shunt: mid-term clinical and angiographic follow-up. J Vasc Interv Radiol 1996;7:255-61.

12. Mercado MA, Takahashi T, Rojas G, Prado E, Hernández J, Tielve FM, Orozco H. Surgery in portal hypertension. Which patient and which operation? Rev Invest Clin 1993;45:329-37.

13. Mercado MA, Morales JC, Granados J, Gómez-Méndez JM, Chan C, Orozco H. Distal splenorenal shunt versus 10 mm low diameter mesocaval shunt for variceal hemorrhage. Am J Surg 1996;171(6):1-5.

14. Orozco H, Mercado MA. Complete portoazygos disconnection for the treatment of bleeding portal hypertension. HPB 1999;2:99-103.

15. Inokuchi K, Cooperative study group of portal hypertension in Japan. Improved survival after prophylactic portal nondecompressive surgery for esophageal varices: a randomized controlled trial. Hepatology 1990;12:1-6.

16. Orloff J, Orloff MS, Orloff SL, Rambotti M, Girard B. Three decades of esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995;179:257-72.

17. Iwatsuki S, Starzl TE, Todo D et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988;104:697-705.

18. Orozco H, Mercado MA, Chan C, Guillén-Navarro E, López-Martínez LM. Comparative study of the elective treatment of variceal hemorrhage by means of b-blockers, transendoscopic sclerotherapy and surgery. A prospective, controlled and randomized trial ten years follow up. Ann Surg 2000;232:216-219.

19. Wood RP, Shaw BW, Rikkers LF. Liver transplantation for variceal hemorrhage. Surg Clin North Am 1990;70:449-61.

20. Bismuth H, Adams R, Mathur S, Sherlock D. Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. Am J Surg 1990;160:105-10.

21. Henderson JM, Gilmore GT, Hooks MA, et al. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992;216:248-55.